The UK government is proposing a nationwide screening program for newborns, aiming to identify a wide array of rare genetic conditions. While proponents highlight the potential for early intervention and improved health outcomes, neurologist Suzanne O'Sullivan raises significant ethical and medical concerns. These concerns include the accuracy of the tests, the potential for false positives, and the psychological impact on families, as well as the broader implications of widespread genetic data collection.